Earnings Estimates Rising for Itron (ITRI): Will It Gain?

13.03.25 17:20 Uhr

Werte in diesem Artikel
Aktien

96,00 EUR 2,00 EUR 2,13%

Indizes

935,5 PKT -8,9 PKT -0,94%

Investors might want to bet on Itron (ITRI), as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price momentum, and this trend might continue with its still improving earnings outlook.Analysts' growing optimism on the earnings prospects of this energy and water meter company is driving estimates higher, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. Our stock rating tool -- the Zacks Rank -- has this insight at its core.The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annual return of +25% since 2008.For Itron, there has been strong agreement among the covering analysts in raising earnings estimates, which has helped push consensus estimates considerably higher for the next quarter and full year.Current-Quarter Estimate RevisionsFor the current quarter, the company is expected to earn $1.28 per share, which is a change of +3.23% from the year-ago reported number.The Zacks Consensus Estimate for Itron has increased 23.78% over the last 30 days, as four estimates have gone higher compared to no negative revisions.Current-Year Estimate RevisionsFor the full year, the company is expected to earn $5.27 per share, representing a year-over-year change of -6.23%.In terms of estimate revisions, the trend for the current year also appears quite encouraging for Itron. Over the past month, seven estimates have moved higher compared to no negative revisions, helping the consensus estimate increase 12.19%.Favorable Zacks RankThanks to promising estimate revisions, Itron currently carries a Zacks Rank #2 (Buy). The Zacks Rank is a tried-and-tested rating tool that helps investors effectively harness the power of earnings estimate revisions and make the right investment decision. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.Our research shows that stocks with Zacks Rank #1 (Strong Buy) and 2 (Buy) significantly outperform the S&P 500.Bottom LineItron shares have added 5.5% over the past four weeks, suggesting that investors are betting on its impressive estimate revisions. So, you may consider adding it to your portfolio right away to benefit from its earnings growth prospects.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.3% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Itron, Inc. (ITRI): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Itron

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Itron

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Itron Inc.

Wer­bung

Analysen zu Itron Inc.

DatumRatingAnalyst
28.02.2019Itron BuyNeedham & Company, LLC
27.02.2018Itron BuyCanaccord Adams
26.07.2017Itron NeutralRobert W. Baird & Co. Incorporated
01.03.2017Itron BuyNeedham & Company, LLC
14.11.2016Itron BuyNeedham & Company, LLC
DatumRatingAnalyst
28.02.2019Itron BuyNeedham & Company, LLC
27.02.2018Itron BuyCanaccord Adams
01.03.2017Itron BuyNeedham & Company, LLC
14.11.2016Itron BuyNeedham & Company, LLC
03.03.2016Itron BuyArgus Research Company
DatumRatingAnalyst
26.07.2017Itron NeutralRobert W. Baird & Co. Incorporated
07.10.2015Itron HoldGabelli & Co
11.09.2015Itron PerformOppenheimer & Co. Inc.
05.05.2015Itron Market PerformNorthland Capital
12.02.2015Itron Market PerformNorthland Capital
DatumRatingAnalyst
15.10.2012Itron sellStifel, Nicolaus & Co., Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Itron Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen